Literature DB >> 35626

Medical management of chronic cancer pain.

D S Shimm, G L Logue, A A Maltbie, S Dugan.   

Abstract

Management of the chronic pain of cancer is a common and difficult problem. In addition to a medical examination of the patient, it is necessary to perform a psychological assessment of his premorbid personality, current mental status, and coping mechanisms to devise an individualized approach to his pain. The mainstay of cancer pain control are the narcotics, which differ primarily in potency and duration of action. Nonnarcotic analgesics are equianalgesic with the less potent narcotics. Antipsychotic drugs are useful as tranquilizers, antiemetics, and analgesic potentiators. Antidepressants and hypnotics permit the patient a more normal life-style. Stimulants such as cocaine and amphetamines both potentiate narcotic analgesia and reduce narcotic-induced somnolence and respiratory depression. Tetrahydrocannabinol offers no advantage over traditional analgesics. With care and patience, the physician can render practically any cancer patient pain-free.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35626

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Effect of chlorpromazine on drug absorption and gastric emptying in man.

Authors:  O U Petring; B Adelhøj; M Ibsen; H E Poulsen
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

Review 2.  Review of general surgery 1979.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

Review 3.  Drug management of pain in cancer patients.

Authors:  C B Tuttle
Journal:  Can Med Assoc J       Date:  1985-01-15       Impact factor: 8.262

4.  The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.

Authors:  R Dallmann; P Weyermann; C Anklin; M Boroff; K Bray-French; B Cardel; I Courdier-Fruh; H Deppe; J Dubach-Powell; M Erb; R H Haefeli; M Henneböhle; H Herzner; M Hufschmid; D L Marks; S Nordhoff; M Papp; C Rummey; G Santos; F Schärer; H Siendt; M Soeberdt; L T Sumanovski; M Terinek; C Mondadori; N Güven; A Feurer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-28       Impact factor: 12.910

5.  Differential effects of the D- and L- isomers of amphetamine on pharmacological MRI BOLD contrast in the rat.

Authors:  Neil Easton; Fiona Marshall; Kevin C F Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2007-03-27       Impact factor: 4.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.